Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A TSPO ligand is protective in a mouse model of multiple sclerosis.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
B lymphocytes in neuromyelitis optica.
Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Multiple sclerosis susceptibility alleles in African Americans.
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
New methods for multiple sclerosis drug discovery.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Words: Perception, "-Omics" Another Epidemic? Vaccine Optic Neuritis; An Amblyopia Symposium; Strasbismus surgery anesthesia.
A Potent and Selective S1P(1) Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
Reducing falls and improving mobility in multiple sclerosis.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Management of pain in advanced disease.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Which immune cells matter? The immunopathogenesis of multiple sclerosis.
Encephalitis followed by optic neuritis: a case report and review of literature.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Pages
« first
‹ previous
…
283
284
285
286
287
288
289
290
291
…
next ›
last »